Klin Monbl Augenheilkd 2021; 238(07): 797-802
DOI: 10.1055/a-1275-0703
Klinische Studie

Evaluation of Retinal Neurodegeneration and Choroidal Thickness in Patients with Inactive Gravesʼ Ophthalmopathy

Beurteilung der retinalen Neurodegeneration und der Dicke der Aderhaut bei Patienten mit inaktiver Graves-Ophthalmopathie
Muhammed M. Kurt
1   Ophthalmology, Samsun Gazi Community Hospital, Samsun, Turkey
,
2   Ophthalmology, Sisli Hamidiye Etfal Egitim ve Arastirma Hastanesi, Istanbul, Turkey
,
Ferhat Evliyaoglu
3   Ophthalmology, Umraniye Training and Research Hospital, Istanbul, Turkey
,
Merve Yilmaz
4   Endocrinology, Samsun Gazi Community Hospital, Samsun, Turkey
,
Fikriye Ordulu
1   Ophthalmology, Samsun Gazi Community Hospital, Samsun, Turkey
› Author Affiliations

Abstract

Purpose The study was conducted for the assessment of the retinal nerve fiber layer, ganglion cell layer, and subfoveal choroidal thickness changes in patients with inactive Gravesʼ ophthalmopathy (GO) using swept-source optical coherence tomography (SS-OCT) before the development of active GO findings.

Materials and Methods The cross-sectional designed study consisted of patients with inactive Gravesʼ ophthalmopathy (study group) and healthy subjects (control group). The thicknesses of the retinal ganglion cell layer, retinal nerve fiber layer, and subfoveal choroid (SFCT) were measured using SS-OCT with deep range imaging technology to compare these parameters between the study and control groups.

Result Patients with inactive Gravesʼ ophthalmopathy had higher values of intraocular pressure but similar best-corrected visual acuity (p = 0.001, p = 0.232, respectively). The retinal nerve fiber layer was thinner only in the superior zone of the study group (p = 0.039), whereas similar values were noted in the temporal, nasal, and inferior areas as well as the average thickness. We did not observe any statistically significant difference in any sector of the ganglion cell layer between the study and control groups. A thicker mean subfoveal choroidal thickness value was measured in patients with inactive Gravesʼ ophthalmopathy than in healthy subjects (p = 0.013) in correlation with a clinical activity score (p = 0.046).

Conclusion SS-OCT showed minimal retinal neurodegenerative alteration and significant choroidal thickening in inactive GO. Thus, SS-OCT might be a beneficial technique to detect retinal neurodegenerative and choroidal changes earlier in the stage of inactive GO before the development of active GO signs, which may affect the time and type of treatment modalities to prevent further ocular or systemic complications. Additionally, SFCT may be a good indicator for assessment of the severity of Gravesʼ disease.

Zusammenfassung

Zweck Die Studie wurde durchgeführt, um die Veränderungen der Nervenfaserschicht der Netzhaut, der Ganglienzellschicht und der subfovealen Dicke der Aderhaut bei Patienten mit inaktiver Graves-Ophthalmopathie (GO) vor der Entwicklung von aktiven GO-Befunden mithilfe der optischen Kohärenztomografie (SS-OCT) zu untersuchen.

Material und Methoden Die Querschnittsstudie bestand aus Patienten mit inaktiver Graves-Ophthalmopathie (Studiengruppe) und gesunden Probanden (Kontrollgruppe). Die Dicken der Ganglienzellschicht der Netzhaut, der Nervenfaserschicht der Netzhaut und der subfovealen Aderhaut (SFCT) wurden unter Verwendung von SS-OCT mit Tiefenbildgebungstechnologie gemessen, um diese Parameter zwischen der Studien- und der Kontrollgruppe zu vergleichen.

Ergebnisse Patienten mit inaktiver Graves-Ophthalmopathie hatten höhere Augeninnendruckwerte, aber eine ähnliche bestkorrigierte Sehschärfe (p = 0,001, p = 0,232). Die Netzhautnervenfaserschicht war nur in der oberen Zone der Studiengruppe dünner (p = 0,039), während ähnliche Werte im temporalen, nasalen und unteren Bereich sowie in der durchschnittlichen Dicke festgestellt wurden. Wir haben in keinem Sektor der Ganglienzellschicht einen statistisch signifikanten Unterschied zwischen der Studien- und der Kontrollgruppe beobachtet. Bei Patienten mit inaktiver Graves-Ophthalmopathie wurde in Korrelation mit dem klinischen Aktivitätsscore (p = 0,046) ein dickerer mittlerer subfovealer Wert für die Dicke der Aderhaut gemessen als bei gesunden Probanden (p = 0,013).

Schlussfolgerung Die SS-OCT zeigte eine minimale neurodegenerative Veränderung der Netzhaut und eine signifikante Verdickung der Aderhaut bei inaktiver GO. Daher könnte die SS-OCT eine vorteilhafte Technik sein, um neurodegenerative und choroidale Veränderungen der Netzhaut früher im Stadium inaktiver GO vor der Entwicklung aktiver GO-Zeichen zu erkennen, was die Zeit und Art der Behandlungsmodalitäten beeinflussen kann, um weitere okulare oder systemische Komplikationen zu verhindern. Darüber hinaus kann die SFCT ein guter Indikator für die Beurteilung der Schwere des Morbus Basedow sein.



Publication History

Received: 26 April 2020

Accepted: 26 September 2020

Article published online:
17 March 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Bartalena L, Baldeschi L, Boboridis K. et al. European Group on Gravesʼ Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Gravesʼ Orbitopathy Guidelines for the Management of Gravesʼ Orbitopathy. Eur Thyroid J 2016; 5: 9-26
  • 2 Burch HB, Wartofsky L. Gravesʼ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747-793
  • 3 Bahn RS, Heufelder AE. Pathogenesis of Gravesʼ ophthalmopathy. N Engl J Med 1993; 329: 1468-1475
  • 4 Prummel M, Bakker A, Wiersinga WM. et al. Multi-center study on the characteristics and treatment strategies of patients with Gravesʼ orbitopathy: the first European Group on Gravesʼ orbitopathy experience. Eur J Endocrinol 2003; 148: 491-495
  • 5 Kalmann R, Mourits MP. Prevalence and management of elevated intraocular pressure in patients with Gravesʼ orbitopathy. Br J Ophthalmol 1998; 82: 754-757
  • 6 Lim HB, Lee MW, Park JH. et al. Changes in Ganglion Cell-Inner Plexiform Layer Thickness and Retinal Microvasculature in Hypertension: An Optical Coherence Tomography Angiography Study. Am J Ophthalmol 2019; 199: 167-176
  • 7 Cohen SY, Miere A, Nghiem-Buffet S. et al. Clinical applications of optical coherence tomography angiography: What we have learnt in the first 3 years. Eur J Ophthalmol 2018; 28: 491-502
  • 8 Soomro T, Talks J. Medscape. The use of optical coherence tomography angiography for detecting choroidal neovascularization, compared to standard multimodal imaging. Eye (Lond) 2018; 32: 661-672
  • 9 de Carlo TE, Romano A, Waheed NK. et al. A review of optical coherence tomography angiography (OCTA). Int J Retina Vitreous 2015; 1: 5
  • 10 Hagag AM, Gao SS, Jia Y. et al. Optical coherence tomography angiography: Technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol 2017; 7: 115-129
  • 11 Yu N, Zhang Y, Kang L. et al. Analysis in Choroidal Thickness in Patients with Gravesʼ Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography. J Ophthalmol 2018; 2018: 3529395
  • 12 Konuk O, Onaran Z, Ozahan OS. et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Gravesʼ orbitopathy: relation with the clinical features. Graefes Arch Clin Exp Ophthalmol 2009; 247: 1555-1559
  • 13 Goncalves ACP, Gebrim EMMS, Monteiro MLR. Imaging studies for diagnosing Gravesʼ orbitopathy and dysthyroid optic neuropathy. Clinics (San Paulo) 2012; 67: 1327-1334
  • 14 Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol 2015; 133: 629-630
  • 15 Çalışkan S, Acar M, Gürdal C. Choroidal thickness in patients with Gravesʼ ophthalmopathy. Curr Eye Res 2017; 42: 484-490
  • 16 Kaushik S, Kataria P, Jain V. et al. Evaluation of macular ganglion cell analysis compared to retinal nerve fiber layer thickness for preperimetric glaucoma diagnosis. Indian J Ophthalmol 2018; 66: 511-516
  • 17 Tezel G, Wax MB. Glial modulation of retinal ganglion cell death in glaucoma. J Glaucoma 2003; 12: 63-68
  • 18 Mayama C, Saito H, Hirasawa H. et al. Diagnosis of early-stage glaucoma by grid-wise macular inner retinal layer thickness measurement and effect of compensation of disc-fovea inclination. Invest Ophthalmol Vis Sci 2015; 56: 5681-5690
  • 19 Shin J, Kwon JM, Park SH. et al. Diagnostic ability of macular vessel density in the ganglion cell-inner plexiform layer on optical coherence tomographic angiography for glaucoma. Transl Vis Sci Technol 2019; 8: 12
  • 20 Rao HL, Pradhan ZS, Weinreb RN. et al. A comparison of the diagnostic ability of vessel density and structural measurements of optical coherence tomography in primary open-angle glaucoma. PLoS One 2017; 12: e0173930
  • 21 Park KA, Kim YD, Woo KI. Changes in optical coherence tomography measurements after orbital wall decompression in dysthyroid optic neuropathy. Eye (Lond) 2018; 32: 1123-1129
  • 22 Wei YH, Chi MC, Liao SL. Predictability of visual function and nerve fiber layer thickness by cross-sectional areas of extraocular muscles in graves ophthalmopathy. Am J Ophthalmol 2011; 151: 901-906
  • 23 Forte R, Bonavolontà P, Vassallo P. Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in thyroid-associated orbitopathy. Ophthalmologica 2010; 224: 116-121
  • 24 Blum Meirovitch S, Leibovitch I, Kesler A. et al. Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy. Isr Med Assoc J 2017; 19: 277-281
  • 25 Mugdha K, Kaur A, Sinha N. et al. Evaluation of retinal nerve fiber layer thickness profile in thyroid ophthalmopathy without optic nerve dysfunction. Int J Ophthalmol 2016; 9: 1634-1637
  • 26 Bruscolini A, La Cava M, Gharbiya M. et al. Management of patients with Gravesʼ disease and orbital involvement: role of spectral-domain optical coherence tomography. J Immunol Res 2018; 2018: 1454616
  • 27 Karabas L, Esen F, Celiker H. et al. Decreased subfoveal choroidal thickness and failure of emmetropisation in patients with oculo-cutaneous albinism. Br J Ophthalmol 2014; 98: 1087-1090
  • 28 Özkan B, Koçer ÇA, Altintaş Ö. et al. Medscape. Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves orbitopathy. Eye (Lond) 2016; 30: 917-924
  • 29 Shinohara Y, Kashima T, Akiyama H. et al. Alteration of choroidal thickness in a case of carotid-cavernous fistula: a case report and a review of the literature. BMC Ophthalmol 2013; 13: 75
  • 30 Chhablani JK, Deshpande R, Sachdeva V. et al. Choroidal thickness profile in healthy Indian children. Indian J Ophthalmol 2015; 63: 474-477
  • 31 Sacconi R, Deotto N, Merz T. et al. SD-OCT Choroidal Thickness in Advanced Primary Open-Angle Glaucoma. J Glaucoma 2017; 26: 523-527